Skip to Main Content

Paper Details

Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
J Am Acad Dermatol
15
2023
Author NameAffiliation
Shadmehr DemehriMassachusetts General Hospital, Harvard Medical School, Center for Cancer Immunology and Cutaneous Biology Research Center, Center for Cancer Research, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital and Harvard Medical School
Kun-Hsing YuHarvard Medical School
  • 1 - 2

Datasets